Guest post by Prof. Manuel Gonzalez de la Rosa: How can a very abnormal GDF, be compatible with the presence of only a few areas of low hemoglobin concentration?
A paper has been accepted in the prestigious British Journal of Ophthalmology, demonstrating that Laguna ONhE/RetinaLyze Glaucoma has a diagnostic capability similar to a modern and expensive Angio-OCT.
The entire RetinaLyze team and their partners were close to our customers this year. At a total of six exhibition stands, visitors were able to learn more about eye screening using artificial intelligence.
Meet us at OPTI 2020 and try the artificial intelligence enabled eye-screening software, RetinaLyze. Find us in Hall C6 Booth 426 from the 10th to the 12th of January 2020
We are proud to present RetinaLyze version 3.7.1, which consists of upgrades to the Glaucoma algorithm.
Professor Gonzalez de la Rosa (GR), prime inventor of the Laguna ONhE/RetinaLyze Glaucoma algorithm, was invited to lecture at two recent meetings in Madrid.
2018 was quite a year for RetinaLyze System A/S (Ltd.). We launched the glaucoma-algorithm, gave RetinaLyze a visual overhaul and reached 1 million screenings for Diabetic Retinopathy, AMD and Glaucoma!
RetinaLyze teams up with two universities to develop the next generation of eye screening algorithms, which may detect new diseases in retinal images, such as Alzheimer's.
The Rotary Medical Mission (RMM) is in Malawi to provide free eye services including provision of eye and sun glasses, and check ups. Our Head of Global Sales, Lasse Bundgaard, joined them in Lilongwe, Malawi at the Kamuzu Central Hospital.
We are proud to present RetinaLyze version 3.2.0, which consists of major upgrades to the Glaucoma algorithm and smaller changes to make the system easier to use.
We're proud to announce our partnership with Unica Pharma, who launched the RetinaLyze Glaucoma software in Argentina this weekend. The software was presented by Dr. Jens Thygesen at the IX Biennial Congress of Glaucoma organized by ASAG.
In this article, we're going to be specifically looking at the importance of regular eye checks and what happens if you neglect to visit your local GP, or ophthalmic specialist.
A team of researchers have developed an algorithm, which automatically detects abnormalities and changes linked to the eye disease glaucoma. The new algorithm is now offered as a part of the software, RetinaLyze, which provides instant eye screening results for the 3 most frequent diseases causing blindness glaucoma, macular degeneration and diabetic retinopathy.
We are excited to present a fantastic new service in the RetinaLyze portfolio. RetinaLyze Glaucoma can screen for glaucoma using only fundus images, but achieves similar performance to OCT's and visual perimetry.
Glaucoma is becoming an increasingly important cause of blindness, as the world’s population ages. New statistics gathered by WHO in 2002, show that glaucoma is now the second leading cause of blindness globally, after cataracts.
Danke! Thank you! Grazie! Merci! Gracias! Teşekkür ederiz! Bedankt! Спасибо! 谢谢! The RetinaLyze team thanks all visitors for a great fair in Munich and look forward to opti 2019!
Wow, 2017 was quite a year for RetinaLyze System A/S. We've screened over 150.000 people for Diabetic Retinopathy and AMD, won an award and launched both massive features and a host of enhancements.
Meet us at OPTI 2018 and try the artificial intelligence enabled eye-screening software, RetinaLyze. Find us in Hall C4 Stand 525 from the 12th to the 14th of January 2018
Aarhus Municipality and CareWare-Next awarded the CareWare-Next prizes, the nationwide competition for welfare technology, on Tuesday November 14th.
Eight welfare technologies and aids were nominated in the CareWare-Next competition on Wednesday 11 October.
We are proud to present RetinaLyze version 2.1.6, which consists of small improvements to make the system easier to use.
We are excited to be entering Uganda with our automated eye screening solution for the first time. We had our first ever attendance of the COECSA meeting in Kampala, Uganda this year.
We saw 49 patients at our outreach diabetic retinal screening clinic in Kampala, Uganda referring 16 for a range of eye conditions.
We are excited to present a fantastic new product in the RetinaLyze portfolio. We have been working on it for quite some time, and are looking forward to the new possibilities the product creates.
Here is a series of images taken during a training session Terry Cooper and Paul Machengo attended at Coast Provincial General Hospital in Mombasa, Kenya.
We’re excited to announce that Terry Cooper (former Regional Manager at VOLK optical) will soon be joining us in the important UK market.
We are proud to present RetinaLyze version 2.1.0, which consists of small improvements to make the system easier to use.
We are proud to present RetinaLyze version 2.0.1, which consists of an added photo quality assessment, speed optimizations, and even better security.
We are proud to present RetinaLyze version 1.3.4, which consists of a series of updates for the Eye-Specialist Backup and a new printable PDF for all customers as standard.
On this day, Valentine’s Day, romance and hearts are all around us – even in our eyes – literally. These photos are a submission of a 59-year-old female from Greece, who has Stargardt’s disease.
World Diabetes Day, November 14, is an annual reoccurring day, where diabetes is in focus. This year’s theme “Eyes on Diabetes” is a theme well aligned with our mission in RetinaLyze: Preventing blindness.
Many diabetes complications can be picked up in their early stages by screening programmes that allow treatment to prevent them from becoming more serious.
Disruptive innovation theory – what is it actually all about? Disruption has indeed become a buzzword! In such an extent that even our law company is hosting an event with the headline “Digitalization and disruption – from buzzword to business”.
The theme of World Diabetes Day 2016 is Eyes on Diabetes, with particular focus on promoting the importance of screening to ensure early diagnosis of type 2 diabetes and treatment to reduce the risk of serious complications.
Health care is changing at a rapid level, and it is amazing what people are doing in research and in advancing the field – trying to make care for patients better. The American Academy of Ophthalmology (AAO) hosted their annual meeting with the overall theme of this year: Innovate
In cooperation with Novo Nordisk, our Kenyan team set out to create awareness about eye screening and diabetes complication in hospitals and rural areas.
The Hall of Frames – “The exhibition for beautiful glasses” (as the official tagline states) – takes departure in the glasses industry and sets the stage for introducing and discussing several themes of relevance for optometrists operating in this market.
We met clinicians who were amazed by the opportunity to let their nurses or even non-medical personal perform retinal image capturing and pre-screening using the RetinaLyze software, letting them focus on diagnosing and treat patients who are not healthy.
We are proud to present RetinaLyze version 1.3.1, which consists of a new search feature, support for timezones and a lot of backend re-structuring to allow for a more scalable and flexible system.
We are proud to present RetinaLyze version 1.3.0, which consists of some major design changes, changes in the AMD-analysis’ results, the addition of new features and a lot of new languages.
This past November, Retinalyze Spain and the Eyes of the World Foundation signed a three-year partnership.
European Society Of Cataract & Retractive Surgeons 2015 is coming to an end. We’d like to take thank all visitors and business partners for the overwhelming interest in the RetinaLyze screening software.
You can make it a weekly habit to cover one eye with your hand and check whether there is a difference in the number of persons and item as well as any difference in the subtitles when watching TV.
The doctors in the british city of Manchester have successfully made the world’s first bionic eye implant.
Since we are experiencing an increase in demand caused by an increased focus on retinal screening to detect diabetes related eye diseases, we are looking for distributors worldwide.
RetinaLyze version 1.2.3 is a smaller update that consists of a few additions.
We are proud to present RetinaLyze version 1.2.4. This version brings a number of updates that make the daily use of RetinaLyze easier and faster.
We have just completed the first training workshops over two wonderful days with around 120 highly competent opticians/optometrists from Profil Optik.
We are proud to present RetinaLyze version 1.2.2, which consists of a few minor design changes and a better experience in older browsers (specifically Internet Explorer 8 and younger), together with a new Help Center with guides and news.
We are proud to present RetinaLyze version 1.2.1 that brings the possibility to zoom in on and download photographs (with and without indications). In addition, the working area is translated into Danish and there are large improvements in terms of safety.